Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

216 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Combination chemotherapy with mitomycin, vindesine, and cisplatin for non-small cell lung cancer. Association of antitumor activity with initial tumor burden and treatment center.
Joss RA, Bürki K, Dalquen P, Schatzmann E, Leyvraz S, Cavalli F, Ludwig C, Siegenthaler P, Alberto P, Stahel R, et al. Joss RA, et al. Among authors: leyvraz s. Cancer. 1990 Jun 1;65(11):2426-34. doi: 10.1002/1097-0142(19900601)65:11<2426::aid-cncr2820651104>3.0.co;2-3. Cancer. 1990. PMID: 2159837 Clinical Trial.
Quality versus quantity of life in the treatment of patients with advanced small-cell lung cancer? A randomized phase III comparison of weekly carboplatin and teniposide versus cisplatin, adriamycin, etoposide alternating with cyclophosphamide, methotrexate, vincristine and lomustine. Swiss Group for Clinical Cancer Research (SAKK).
Joss RA, Alberto P, Hürny C, Bacchi M, Leyvraz S, Thürlimann B, Cerny T, Martinelli G, Stahel R, Ludwig C. Joss RA, et al. Among authors: leyvraz s. Ann Oncol. 1995 Jan;6(1):41-8. doi: 10.1093/oxfordjournals.annonc.a059039. Ann Oncol. 1995. PMID: 7536028 Free article. Clinical Trial.
Rapidly alternating combination of cisplatin-based chemotherapy and hyperfractionated accelerated radiotherapy in split course for stage IIIA and stage IIIB non-small cell lung cancer: results of a phase I-II study by the GOTHA group. Group d'Oncologie Thoracique des Régions Alpines.
Alberto P, Mirimanoff RO, Mermillod B, Leyvraz S, Nagy-Mignotte H, Bolla M, Wellmann D, Moro D, Brambilla E. Alberto P, et al. Among authors: leyvraz s. Eur J Cancer. 1995;31A(3):342-8. doi: 10.1016/0959-8049(94)00484-m. Eur J Cancer. 1995. PMID: 7786599 Clinical Trial.
Adjuvant chemotherapy in operable breast cancer: cyclophosphamide, methotrexate, and fluorouracil versus chlorambucil, methotrexate, and fluorouracil--11-year results of Swiss Group for Clinical Cancer Research trial SAKK 27/82.
Senn HJ, Maibach R, Castiglione M, Jungi WF, Cavalli F, Leyvraz S, Obrecht JP, Schildknecht O, Siegenthaler P. Senn HJ, et al. Among authors: leyvraz s. J Clin Oncol. 1997 Jul;15(7):2502-9. doi: 10.1200/JCO.1997.15.7.2502. J Clin Oncol. 1997. PMID: 9215818 Clinical Trial.
The impact of adding low-dose leucovorin to monthly 5-fluorouracil in advanced colorectal carcinoma: results of a phase III trial. Swiss Group for Clinical Cancer Research (SAKK).
Borner MM, Castiglione M, Bacchi M, Weber W, Herrmann R, Fey MF, Pagani O, Leyvraz S, Morant R, Pestalozzi B, Hanselmann S, Goldhirsch A. Borner MM, et al. Among authors: leyvraz s. Ann Oncol. 1998 May;9(5):535-41. doi: 10.1023/a:1008270916325. Ann Oncol. 1998. PMID: 9653495 Free article. Clinical Trial.
216 results